SARS-CoV-2-linked hospitalization, ED encounters rare after Paxlovid
Jun 28, 2022
<1 percent of patients to whom Paxlovid was dispensed for mild-to-moderate COVID-19 had a hospitalization or emergency department encounter.
CDC: Monitoring of COVID-19 will remain a priority
May 08, 2023
Surveillance of COVID-19 and COVID-19-associated mortality after expiration of the COVID-19 public health emergency declaration on May 11 will continue.
Rehospitalization in dementia patients tied to nurse continuity
Jun 28, 2021
Wide variation was seen in continuity of nursing staff for home healthcare visits to dementia patients following hospitalization.
For many, myocarditis risk higher after SARS-CoV-2 infection than vaccination
Aug 23, 2022
But the myocarditis risk was higher after vaccination for men younger than age 40 years, particularly after the second dose of mRNA-1273.
~30 percent of seniors have sequelae after acute SARS-CoV-2
Feb 10, 2022
The greatest excess risk was seen for respiratory failure, fatigue, hypertension and memory difficulties compared with matched individuals without COVID-19.
SARS-CoV-2 infection up >90 days since second BNT162b2 dose
Nov 29, 2021
Individuals who tested positive for SARS-CoV-2 had a significantly longer time elapsed since Pfizer-BioNTech vaccine injection.
Asymptomatic SARS-CoV-2 infection seems to be less common
Feb 28, 2022
The study showed that 12 of 12 healthcare workers who received a diagnosis of SARS-CoV-2 infection had at least mild symptoms.
High coffee intake linked to CVD mortality in severe hypertension
Dec 21, 2022
“These findings may support the assertion that people with severe high blood pressure should avoid drinking excessive coffee,” a coauthor said in a statement.
48.3 percent of U.S. ≥16s have had at least one dose of COVID-19 vaccine
Jul 15, 2021
As of May 15, 2021, coverage was lower for non-Hispanic Blacks and Hispanics versus whites; higher for those at risk for severe COVID-19.
Convalescent plasma use inversely inked to COVID-19 mortality
Jun 14, 2021
A reduction in convalescent plasma use may have resulted in 29,000 excess deaths in the U.S. from mid-November 2020 to February 2021.